1358
K. Kolodziejczyk et al.
General procedure for formation of compounds 1a–1f
N-(2-(4-Fluorophenyl)-3-furyl)-1-methyl-4-(trifluoro-
methyl)-1H-pyrrole-3-carboxamide (1c, C17H12F4N2O2)
According to procedure D 1c was obtained as a yellow
Procedure C: To a solution of amine (9a–9c, 2.07 mmol) in
7 cm3 dry CH2Cl2 DMAP (3.11 mmol) was added and
then, dropwise, the acid chloride 11a–11b (2.07 mmol)
dissolved in 7 cm3 dry CH2Cl2. The resulting solution was
stirred at room temperature for 23–40 h. Then the reaction
mixture was quenched with 5 cm3 2 M HCl, extracted with
CH2Cl2 (2 9 15 cm3), the combined organic layers dried
over Na2SO4, and then the solvent was evaporated,
affording the desired amide.
1
solid (53%); m.p.: 50–54 °C; H NMR (CDCl3): d = 3.62
(s, 3H, CH3), 6.91 (dd, 1H, H5, 4J = 2.7 Hz,
4JH–F = 1.6 Hz), 6.94 (d, 1H, H40, 3J = 2.0 Hz), 7.02
(dd, 2H, H200, H600, 3J = 8.8 Hz), 7.28 (d, 1H, H2,
4J = 2.7 Hz), 7.31 (d, 1H, H50, 3J = 2.0 Hz), 7.49 (s,
1H, NH), 7.51 (dd, 2H, H300, H500, 3J = 8.8 Hz,
3JH–F = 3.5 Hz) ppm; 13C NMR (CDCl3): d = 36.8 (q,
2
CH3), 110.2 (d, C40), 111.6 (q, C4, JC–F = 36.2 Hz),
Procedure D: To
a
solution of amine (9a–9c,
115.8 (d, C300, C500, 2JC–F = 21.8 Hz), 117.0 (s, C3), 119.8
(s, C30), 123.3 (q, CF3, JC–F = 266.2 Hz), 124.1 (q, C5,
3JC–F = 6 Hz), 126.4 (s, C20), 127.0 (d, C200, C600,
3JC–F = 8 Hz), 129.2 (d, C2), 140.8 (d, C50), 141.9 (s,
C100), 161.0 (s, NHCO), 162.0 (d, C400, JC–F = 247.6 Hz)
ppm.
2.58 mmol) in 7 cm3 dry CH2Cl2 triethylamine
(6.45 mmol) was added. The acid chloride 11a–11b
(2.58 mmol) dissolved in 5 cm3 dry CH2Cl2 was then
added dropwise. The resulting solution was stirred at
room temperature for 38 h. Then the reaction mixture
was quenched with 10 cm3 2 M HCl, extracted with
CH2Cl2 (3 9 40 cm3), dried over Na2SO4 and purified
by flash column chromatography affording the amides
1a–1f.
1-Methyl-N-(2-phenyl-3-furyl)-3-(trifluoromethyl)-1H-pyr-
azole-4-carboxamide (1d, C16H12F3N3O2)
According to procedure D 1d was obtained as a pale brown
1
solid foam (26%); m.p.: 145–150 °C; H NMR (CDCl3):
d = 3.86 (s, 3H, CH3), 6.92 (bs, 1H, H40), 7.22 (m, 1H,
1-Methyl-N-(2-phenyl-3-furyl)-4-(trifluoromethyl)-1H-
pyrrole-3-carboxamide (1a, C17H13F3N2O2)
According to procedure C 1a was obtained as a yellow
H400), 7.29–7.37 (m, 2H, H300, H500), 7.32 (d, 1H, H50,
3
3J = 2.0 Hz), 7.49 (d, 2H, H200, H600, J = 7.0 Hz), 7.69
(bs, 1H, NH), 7.93 (s, 1H, H5) ppm; 13C NMR (CDCl3):
d = 38.8 (q, CH3), 108.9 (d, C40), 115.7 (s, C4), 118.6 (s,
C30), 120.0 (q, CF3, JC–F = 269.2 Hz), 124.1 (d, C200,
C600), 126.8 (d, C400), 127.9 (d, C300, C500), 128.8 (s, C20),
135.1 (d, C5), 136.0 (s, C100), 140.0 (d, C50), 141.4 (q, C3,
2JC–F = 34.5 Hz), 157.8 (s, NHCO) ppm.
1
solid (38%); m.p.: 51–53 °C; H NMR (CDCl3): d = 3.61
(s, 3H, CH3), 6.90 (dd, 1H, H5, 4J = 2.7 Hz,
4JH–F = 1.6 Hz), 7.00 (d, 1H, H40, 3J = 2.0 Hz), 7.19
4
(m, 1H, H400), 7.25 (d, 1H, H2, J = 2.7 Hz), 7.29–7.38
(m, 2H, H300, H500), 7.33 (d, 1H, H50), 7.53 (d, 2H, H200,
H600, 3J = 7.0 Hz), 7.59 (bs, 1H, NH) ppm; 13C NMR
(CDCl3): d = 35.8 (q, CH3), 109.0 (d, C40), 110.7 (q, C4,
2JC–F = 36.2 Hz), 116.2 (s, C3), 119.3 (s, C30), 121.2 (q,
N-(2-(4-Chlorophenyl)-3-furyl)-1-methyl-3-(trifluoro-
methyl)-1H-pyrazole-4-carboxamide
(1e, C16H11ClF3N3O2)
3
CF3, JC–F = 266.3 Hz), 123.0 (q, C5, JC–F = 6.1 Hz),
124.1 (d, C200, C600), 126.4 (d, C400), 127.8 (d, C300, C500),
128.0 (d, C2), 129.2 (s, C20), 139.9 (d, C50), 141.2 (s, C100),
159.9 (s, NHCO) ppm.
According to procedure D, 1e was obtained as a yellow
solid (35%); m.p.: 172–175 °C; 1H NMR (CDCl3):
d = 3.98 (s, 3H, CH3), 6.99 (br d, 1H, H40), 7.38 (d, 2H,
3
3
H300, H500, J = 8.8 Hz), 7.41 (d, 1H, H50, J = 2.0 Hz),
N-(2-(4-Chlorophenyl)-3-furyl)-1-methyl-4-(trifluoro-
methyl)-1H-pyrrole-3-carboxamide
(1b, C17H12ClF3N2O2)
3
7.53 (d, 2H, H200, H600, J = 8.8 Hz), 7.61 (bs, 1H, NH),
8.03 (s, 1H, H5) ppm; 13C NMR (DMSO-d6): d = 39.4 (q,
CH3), 112.3 (d, C40), 115.7 (s, C4), 120.4 (s, C30), 120.8 (q,
CF3, JC–F = 268.8 Hz), 126.0 (d, C200, C600), 128.7 (d, C300,
C500), 128.7 (s, C20), 131.7 (s, C400), 134.4 (d, C5), 139.4 (s,
C3, 2JC–F = 37.3 Hz), 141.9 (d, C50), 142.7 (s, C100), 159.0
(s, NHCO) ppm.
According to procedure D 1b was obtained as an orange
1
solid (53%); m.p.: 66–71 °C; H NMR (CDCl3): d = 3.62
(s, 3H, CH3), 6.92 (s, 1H, H5), 6.93 (d, 1H, H40,
3J = 2.0 Hz), 7.26–7.32 (m, 4H, H300, H500, J = 8.8 Hz,
3
3
H50, H2), 7.46 (d, 2H, H200, H600, J = 8.8 Hz), 7.52 (bs,
1H, NH) ppm; 13C NMR (CDCl3): d = 36.9 (q, CH3),
N-(2-(4-Fluorophenyl)-3-furyl)-1-methyl-3-(trifluoro-
methyl)-1H-pyrazole-4-carboxamide
(1f, C16H11F4N3O2)
2
110.4 (d, C40), 111.6 (q, C4, JC–F = 36.2 Hz), 117.0 (s,
C3), 120.5 (s, C30), 123.3 (q, CF3, JC–F = 266.2 Hz), 124.1
3
(q, C5, JC–F = 6.2 Hz), 126.2 (d, C200, C600), 128.6
According to procedure D 1f was obtained as a yellow
solid (67%); m.p. 136–139 °C; 1H NMR (CDCl3):
d = 3.88 (s, 3H, CH3), 6.86 (br d, 1H, H40), 7.02 (dd,
2H, H200, H600, 3J = 8.8 Hz), 7.30 (d, 1H, H50,
(s, C400), 129.0 (d, C300, C500), 129.2 (d, C2), 133.1
(s, C20), 141.1 (d, C50), 141.6 (s, C100), 160.9 (s, NHCO)
ppm.
123